Antidepressant Mechanisms of Transcranial Magnetic Stimulation
Predictive and Response Biomarkers of Effective Treatment With Transcranial Magnetic Stimulation for Major Depressive Disorder
Sponsor: National Alliance for Research on Schizophrenia and Depression
Listed as NCT02466230, this NA trial focuses on Depression and remains completed. Sponsored by National Alliance for Research on Schizophrenia and Depression, it has been updated 11 times since 2011, reflecting substantial change activity. Mental health research at this phase helps define safety and dosing parameters for future study.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2023 — Jul 2024 [monthly]
Completed NA
-
Dec 2022 — Jan 2023 [monthly]
Completed NA
-
Jan 2021 — Dec 2022 [monthly]
Completed NA
▶ Show 6 earlier versions
-
Feb 2020 — Jan 2021 [monthly]
Completed NA
-
Oct 2018 — Feb 2020 [monthly]
Completed NA
-
Jun 2018 — Oct 2018 [monthly]
Completed NA
-
May 2017 — Jun 2018 [monthly]
Completed NA
Phase: PHASE4 → NA
-
Feb 2017 — May 2017 [monthly]
Completed PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE4
First recorded
Jan 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- National Alliance for Research on Schizophrenia and Depression
- Neuronetics
- Weill Medical College of Cornell University
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.